Patents by Inventor Gregory NICOLAS

Gregory NICOLAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted 2,4 diamino-quinoline as new anticancer agents
    Patent number: 10722505
    Abstract: The present invention relates to novel 2-primary amino-4-secondary amino-quinoline derivatives, their manufacture, pharmaceutical compositions comprising them and their use as medicaments. The active compounds of the present invention are useful for the treatment and prevention of proliferative neoplastic and non-neoplastic diseases.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: July 28, 2020
    Assignee: GENOSCIENCE PHARMA
    Inventors: Firas Bassissi, Antoine Beret, Sonia Brun, Jérôme Courcambeck, Clarisse Dubray, Gregory Nicolas, Philippe Halfon
  • SUBSTITUTED 2,4 DIAMINO-QUINOLINE AS NEW ANTICANCER AGENTS
    Publication number: 20190314359
    Abstract: The present invention relates to novel 2-primary amino-4-secondary amino-quinoline derivatives, their manufacture, pharmaceutical compositions comprising them and their use as medicaments. The active compounds of the present invention are useful for the treatment and prevention of proliferative neoplastic and non-neoplastic diseases.
    Type: Application
    Filed: October 26, 2015
    Publication date: October 17, 2019
    Inventors: Firas BASSISSI, Antoine BERET, Sonia BRUN, Jérôme COURCAMBECK, Clarisse DUBRAY, Gregory NICOLAS, Philippe HALFON
  • Quinolines derivatives as novel anticancer agents
    Patent number: 10179770
    Abstract: The invention provides quinoline derivatives, their manufacture, pharmaceutical compositions containing them, and their use as medicaments. The active compounds of the present invention are useful for the treatment of proliferative neoplastic and non-neoplastic diseases.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 15, 2019
    Assignee: GENOSCIENCE PHARMA
    Inventors: Jerome Courcambeck, Philippe Halfon, Firas Bassissi, Sonia Brun, Gregory Nicolas, Antoine Beret, Serge Petit, Claire Camus, Jean Pierre Nallet
  • QUINOLINES DERIVATIVES AS NOVEL ANTICANCER AGENTS
    Publication number: 20160280653
    Abstract: The invention provides quinoline derivatives, their manufacture, pharmaceutical compositions containing them, and their use as medicaments. The active compounds of the present invention are useful for the treatment of proliferative neoplastic and non-neoplastic diseases.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 29, 2016
    Inventors: Jerome COURCAMBECK, Philippe HALFON, Firas BASSISSI, Sonia BRUN, Gregory NICOLAS, Antoine BERET, Serge PETIT, Claire CAMUS, Jean Pierre NALLET